tislelizumab

E1995666 UNEXPLORED

Tislelizumab is a humanized monoclonal antibody immune checkpoint inhibitor used in cancer therapy to enhance anti-tumor immune responses.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label Occurrences
tislelizumab canonical 2

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

programmed cell death protein 1 → targetOfDrug → tislelizumab ⓘ
PD-1 → isTargetOfDrug → tislelizumab ⓘ